MRSA Research - Methicillin-Resistant Staphylococcus Aureus, Hospitals, Infection, Antibiotic Resistance, Superbugs

MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.


MRSA Research Today

Home

View Latest Issue

Information About MRSA

Books on MRSA

Advertising in Research Today

View Other Research Today Publications



Volume 6 (2009), Issue 11 (November)

  1. Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus outbreak among healthcare workers in a long-term care facility.
    Int J Infect Dis, 13(6): e401-6. [Abstract] [Full-text]
  2. Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia.
    Eur Respir J, 34(5): 1148-58. [Abstract] [Full-text]
  3. Transcription of the phage-encoded Panton-Valentine leukocidin of Staphylococcus aureus is dependent on the phage life-cycle and on the host background.
    Microbiology, 155: 3491-9. [Abstract] [Full-text]
  4. Vacuum-assisted closure and bilateral pectoralis muscle flaps for different stages of mediastinitis after cardiac surgery.
    Surg Today, 39(11): 947-54. [Abstract] [Full-text]
  5. What is MRSA?
    Eur Respir J, 34(5): 1190-6. [Abstract] [Full-text]
  6. Infection with methicillin-resistant Staphylococcus pseudintermedius masquerading as cefoxitin susceptible in a dog.
    J Am Vet Med Assoc, 235(9): 1064-6. [Abstract] [Full-text]
  7. Implementation of a universal admission surveillance and decolonization program for methicillin-resistant staphylococcus aureus (MRSA) reduces the number of MRSA and total number of S. aureus isolates reported by the clinical laboratory.
    J Clin Microbiol, 47(11): 3749-52. [Abstract] [Full-text]
  8. Failure of the BD GeneOhm StaphSR assay for direct detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates in positive blood cultures collected in the United States.
    J Clin Microbiol, 47(11): 3747-8. [Abstract] [Full-text]
  9. Molecular and phenotypic characteristics of methicillin-resistant and vancomycin-intermediate staphylococcus aureus isolates from patients with septic arthritis.
    J Clin Microbiol, 47(11): 3617-23. [Abstract] [Full-text]
  10. Two distinct clones of methicillin-resistant Staphylococcus aureus (MRSA) with the same USA300 pulsed-field gel electrophoresis profile: a potential pitfall for identification of USA300 community-associated MRSA.
    J Clin Microbiol, 47(11): 3765-8. [Abstract] [Full-text]
  11. Multiplex real-time PCR for rapid Staphylococcal cassette chromosome mec typing.
    J Clin Microbiol, 47(11): 3692-706. [Abstract] [Full-text]
  12. Comparison of the Xpert methicillin-resistant Staphylococcus aureus (MRSA) assay, BD GeneOhm MRSA assay, and culture for detection of nasal and cutaneous groin colonization by MRSA.
    J Clin Microbiol, 47(11): 3769-72. [Abstract] [Full-text]
  13. Cost-effectiveness of rapid MRSA screening in surgical patients.
    Eur J Clin Microbiol Infect Dis, 28(11): 1291-6. [Abstract] [Full-text]
  14. Comparative activity of oritavancin against meticillin-resistant Staphylococcus aureus (MRSA) bloodstream isolates from Geneva University Hospital.
    Int J Antimicrob Agents, 34(6): 540-3. [Abstract] [Full-text]
  15. Near-infrared photoinactivation of bacteria and fungi at physiologic temperatures.
    Photochem Photobiol, 85(6): 1364-74. [Abstract] [Full-text]
  16. Prevalence and molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) among pigs on German farms and import of livestock-related MRSA into hospitals.
    Eur J Clin Microbiol Infect Dis, 28(11): 1375-82. [Abstract] [Full-text]
  17. Intra-strain variability of methicillin-resistant Staphylococcus aureus strains ST228-MRSA-I and ST5-MRSA-II.
    Eur J Clin Microbiol Infect Dis, 28(11): 1383-90. [Abstract] [Full-text]
  18. Should vascular surgery patients be screened preoperatively for methicillin-resistant Staphylococcus aureus?
    Infect Control Hosp Epidemiol, 30(12): 1158-65. [Abstract] [Full-text]
  19. Analysis of Slovenian MRSA strains with susceptibility patterns suggestive of CA-MRSA.
    Wien Klin Wochenschr, 121(17): 552-557. [Abstract] [Full-text]
  20. Bench-to-bedside review: Understanding the impact of resistance and virulence factors on methicillin-resistant Staphylococcus aureus infections in the intensive care unit.
    Crit Care, 13(5): 222. [Abstract] [Full-text]
  21. MRSA screening: can one swab be used for both culture and rapid testing?An evaluation of chromogenic culture and subsequent Hain GenoQuick PCR amplification/detection.
    Clin Microbiol Infect. [Abstract] [Full-text]
  22. Who are the carriers of MRSA in the community? A prospective study in the Pays de la Loire region of France.
    Clin Microbiol Infect. [Abstract] [Full-text]
  23. Implementation of a methicillin-resistant Staphylococcus aureus (MRSA) prevention bundle results in decreased MRSA surgical site infections.
    Am J Surg, 198(5): 607-10. [Abstract] [Full-text]
  24. Multidrug-resistant gram-negative bacteria at a long-term care facility: assessment of residents, healthcare workers, and inanimate surfaces.
    Infect Control Hosp Epidemiol, 30(12): 1172-9. [Abstract] [Full-text]
  25. Genetic diversity of arginine catabolic mobile element in Staphylococcus epidermidis.
    PLoS One, 4(11): e7722. [Abstract] [Full-text]
  26. Community-acquired methicillin-resistant Staphylococcus aureus pneumonia and ARDS: 1-year follow-up.
    Chest, 136(5): 1407-12. [Abstract] [Full-text]
  27. Twenty-five year epidemiology of invasive methicillin-resistant Staphylococcus aureus (MRSA) isolates recovered at a burn center.
    Burns, 35(8): 1112-7. [Abstract] [Full-text]
  28. Risk factors for acquisition of Methicillin-resistant Staphylococcus aureus among patients from a burn unit in Brazil.
    Burns, 35(8): 1104-11. [Abstract] [Full-text]
  29. The evaluation of novel chromogenic substrates for the detection of lipolytic activity in clinical isolates of Staphylococcus aureus and MRSA from two European study groups.
    FEMS Microbiol Lett, 297(1): 10-6. [Abstract] [Full-text]
  30. Performance of CHROMagar Staph aureus and CHROMagar MRSA for detection of Staphylococcus aureus in seawater and beach sand - comparison of culture, agglutination, and molecular analyses.
    Water Res, 43(19): 4802-11. [Abstract] [Full-text]
  31. Application of a novel decontamination process using gaseous ozone.
    Can J Microbiol, 55(8): 928-33. [Abstract] [Full-text]
  32. Ineffectiveness of surveillance to control community-acquired methicillin-resistant Staphylococcus aureus in a professional football team.
    Clin J Sport Med, 19(6): 498-501. [Abstract] [Full-text]
  33. Clinical importance of purulence in methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    J Am Board Fam Med, 22(6): 647-54. [Abstract] [Full-text]
  34. Linezolid versus vancomycin for MRSA skin and soft tissue infections (systematic review and meta-analysis).
    ANZ J Surg, 79(9): 629-35. [Abstract] [Full-text]
  35. Aerosolized vancomycin for the treatment of MRSA after lung transplantation.
    Respirology. [Abstract] [Full-text]
  36. Constitutive expression of the ileS-2 gene responsible for high-level mupirocin resistance in Staphylococcus aureus.
    J Med Microbiol, 58: 1582-4. [Abstract] [Full-text]
  37. In vitro effect of physiological concentrations of human albumin on the antibacterial activity of tigecycline.
    J Antimicrob Chemother, 64(6): 1230-3. [Abstract] [Full-text]
  38. Antimicrobial efficacy of eucalyptus oil and 1,8-cineole alone and in combination with chlorhexidine digluconate against microorganisms grown in planktonic and biofilm cultures.
    J Antimicrob Chemother, 64(6): 1219-25. [Abstract] [Full-text]
  39. Characterization of methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococcus spp. isolated from US West Coast public marine beaches.
    J Antimicrob Chemother, 64(6): 1148-55. [Abstract] [Full-text]
  40. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    J Antimicrob Chemother, 64(6): 1226-9. [Abstract] [Full-text]
  41. Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies.
    J Antimicrob Chemother, 64(6): 1130-8. [Abstract] [Full-text]
  42. Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) among residents of nursing homes in Belgium.
    J Antimicrob Chemother, 64(6): 1299-306. [Abstract] [Full-text]
  43. Diversity of antimicrobial resistance pheno- and genotypes of methicillin-resistant Staphylococcus aureus ST398 from diseased swine.
    J Antimicrob Chemother, 64(6): 1156-64. [Abstract] [Full-text]
  44. Methicillin-resistant Staphylococcus aureus (MRSA) among dental patients: a problem for infection control in dentistry?
    Clin Oral Investig, 13(4): 369-73. [Abstract] [Full-text]
  45. Life-threatening infection due to community-acquired methicillin-resistant Staphylococcus aureus: case report and review.
    Eur J Pediatr, 169(1): 47-53. [Abstract] [Full-text]
  46. Cardiovascular collapse and vascular permeability changes in an ovine model of methicillin-resistant Staphylococcus aureus sepsis.
    Shock, 32(6): 621-5. [Abstract] [Full-text]
  47. Evaluation of ceftiofur and cefquinome for phenotypic detection of methicillin resistance in Staphylococcus aureus using disk diffusion testing and MIC-determinations.
    Vet Microbiol, 140(1): 176-9. [Abstract] [Full-text]
  48. Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection.
    PLoS One, 4(11): e7804. [Abstract] [Full-text]
  49. Contribution of Dermatologic Surgery in War.
    Dermatol Surg. [Abstract] [Full-text]
  50. Clinical, molecular and epidemiological description of a cluster of community-associated methicillin-resistant Staphylococcus aureus isolates from injecting drug users with bacteraemia.
    Clin Microbiol Infect. [Abstract] [Full-text]
  51. Association of biofilm formation and methicillin-resistance with accessory gene regulator (agr) loci in Greek Staphylococcus aureus clones.
    Microb Pathog, 47(6): 341-4. [Abstract] [Full-text]
  52. A rapid, 2-well, multiplex real-time polymerase chain reaction assay for the detection of SCCmec types I to V in methicillin-resistant Staphylococcus aureus.
    Diagn Microbiol Infect Dis, 65(4): 384-91. [Abstract] [Full-text]
  53. Panton-Valentine leukocidin (PVL)-positive methicillin-susceptible and resistant Staphylococcus aureus in Taiwan: identification of oxacillin-susceptible mecA-positive methicillin-resistant S. aureus.
    Diagn Microbiol Infect Dis, 65(4): 351-7. [Abstract] [Full-text]
  54. Clinical and molecular epidemiology of methicillin-resistant Staphylococcus aureus carrying SCCmecIV in a university hospital in Porto Alegre, Brazil.
    Diagn Microbiol Infect Dis, 65(4): 457-61. [Abstract] [Full-text]
  55. Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008.
    Diagn Microbiol Infect Dis, 65(4): 404-13. [Abstract] [Full-text]
  56. Expanding spectrum of illness due to community-associated methicillin-resistant Staphylococcus aureus: a case report.
    Cases J, 2: 7437. [Abstract] [Full-text]
  57. Beware of the pet dog: a case of Staphylococcus intermedius infection.
    Am J Med Sci, 338(5): 425-7. [Abstract] [Full-text]
  58. Correlation between vancomycin MIC values and those of other agents against gram-positive bacteria among patients with bloodstream infections caused by methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother, 53(12): 5141-4. [Abstract] [Full-text]
  59. Pharmacokinetic-pharmacodynamic modeling of the in vitro activities of oxazolidinone antimicrobial agents against methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother, 53(12): 5039-45. [Abstract] [Full-text]
  60. Activity of the novel peptide arminin against multiresistant human pathogens shows the considerable potential of phylogenetically ancient organisms as drug sources.
    Antimicrob Agents Chemother, 53(12): 5245-50. [Abstract] [Full-text]
  61. Methicillin-resistant Staphylococcus aureus screening by online immunometric monitoring of bacterial growth under selective pressure.
    Antimicrob Agents Chemother, 53(12): 5088-94. [Abstract] [Full-text]
  62. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700).
    Antimicrob Agents Chemother, 53(12): 5265-74. [Abstract] [Full-text]
  63. In vivo activity of a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, ceftaroline, against vancomycin-susceptible and -resistant Enterococcus faecalis strains in a rabbit endocarditis model: a comparative study with linezolid and vancomycin.
    Antimicrob Agents Chemother, 53(12): 5300-2. [Abstract] [Full-text]
  64. Pharmacodynamic profile of tigecycline against methicillin-resistant Staphylococcus aureus in an experimental pneumonia model.
    Antimicrob Agents Chemother, 53(12): 5060-3. [Abstract] [Full-text]
  65. Empirical therapy for serious Gram-positive infections: making the right choice.
    Clin Microbiol Infect, 15: 5-10. [Abstract] [Full-text]
  66. VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers.
    Health Technol Assess, 13(55): 1-182, iii-iv. [Abstract] [Full-text]
  67. Community-associated meticillin-resistant Staphylococcus aureus as a cause of hospital-acquired infections.
    J Hosp Infect, 73(4): 364-70. [Abstract] [Full-text]
  68. Screening and isolation for infection control.
    J Hosp Infect, 73(4): 371-7. [Abstract] [Full-text]
  69. Are national targets the right way to improve infection control practice?
    J Hosp Infect, 73(4): 408-13. [Abstract] [Full-text]
  70. What are the drivers of the UK media coverage of meticillin-resistant Staphylococcus aureus, the inter-relationships and relative influences?
    J Hosp Infect, 73(4): 400-7. [Abstract] [Full-text]
  71. Methicillin-resistant Staphylococcus aureus sepsis presenting with septic pulmonary emboli.
    J Emerg Med, 37(4): 383-5. [Abstract] [Full-text]
  72. Exotoxin-encoding gene content in community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus.
    Clin Microbiol Infect, 15(12): 1139-45. [Abstract] [Full-text]
  73. High-resolution melting analysis of the spa locus reveals significant diversity within sequence type 93 methicillin-resistant Staphylococcus aureus from northern Australia.
    Clin Microbiol Infect, 15(12): 1126-31. [Abstract] [Full-text]
  74. Clinical and molecular epidemiology of community-acquired, healthcare-associated and nosocomial methicillin-resistant Staphylococus aureus in Spain.
    Clin Microbiol Infect, 15(12): 1111-8. [Abstract] [Full-text]
  75. Epidemiology of Staphylococcus aureus nasal colonization and influence on outcome in the critically ill.
    J Crit Care, 24(4): 583-9. [Abstract] [Full-text]
  76. Economic Aspects of the Management and Control of MRSA.
    Gesundheitswesen, 71(11): 771-776. [Abstract] [Full-text]
  77. EUREGIO MRSA-net Twente/Münsterland: "Search & Follow" by Euregional Network Building.
    Gesundheitswesen, 71(11): 766-770. [Abstract] [Full-text]
  78. Liability Risks of MRSA-Management.
    Gesundheitswesen, 71(11): 763-765. [Abstract] [Full-text]
  79. Management of Antibiotic-resistant Pathogens in Bavarian Hospitals: Results of a Systematic Survey and Prospects to Establish a Statewide Network "Multidrug-resistant Pathogens"
    Gesundheitswesen, 71(11): 755-762. [Abstract] [Full-text]
  80. Community-acquired methicillin-resistant Staphylococcus aureus pyomyositis with myelitis: A rare occurrence with diverse presentation.
    Neurol India, 57(5): 653-6. [Abstract] [Full-text]
  81. Methicillin-resistant Staphylococcus aureus aortitis in a cardiac transplant patient.
    Am J Emerg Med, 27(9): 1174.e5-6. [Abstract] [Full-text]
  82. USA300 is the predominant genotype causing Staphylococcus aureus septic arthritis in children.
    Pediatr Infect Dis J, 28(12): 1076-80. [Abstract] [Full-text]
  83. Conformational and dynamics simulation study of antimicrobial peptide hedistin-heterogeneity of its helix-turn-helix motif.
    Biochim Biophys Acta, 1788(12): 2497-508. [Abstract] [Full-text]
  84. Bacteremic methicillin-resistant Staphylococcus aureus deep neck abscess in a newborn--case report and review of literature.
    Int J Pediatr Otorhinolaryngol, 73(12): 1824-7. [Abstract] [Full-text]
  85. Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985-2005.
    J Cyst Fibros, 8(6): 386-91. [Abstract] [Full-text]
  86. Linezolid-associated acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome.
    Am J Kidney Dis, 54(6): e17-20. [Abstract] [Full-text]
  87. Temporal trends in the incidence of Staphylococcus aureus bacteremia in Olmsted County, Minnesota, 1998 to 2005: a population-based study.
    Clin Infect Dis, 49(12): e130-8. [Abstract] [Full-text]
  88. Screening of genes encoding adhesion factors and biofilm formation in Staphylococcus aureus isolates from poultry.
    Avian Pathol, 38(6): 513-7. [Abstract] [Full-text]
  89. Community-associated methicillin-resistant Staphylococcus aureus in acute musculoskeletal infection in children: a game changer.
    J Pediatr Orthop, 29(8): 927-31. [Abstract] [Full-text]
  90. Newer developments in the treatment of Gram-positive infections.
    Expert Opin Pharmacother, 10(17): 2829-43. [Abstract] [Full-text]
  91. Dissemination of methicillin-resistant Staphylococcus aureus USA300 sequence type 8 lineage in Latin America.
    Clin Infect Dis, 49(12): 1861-7. [Abstract] [Full-text]
  92. Telavancin: a novel lipoglycopeptide.
    Clin Infect Dis, 49(12): 1908-14. [Abstract] [Full-text]
  93. "Spider bite" lesions are usually diagnosed as skin and soft-tissue infections.
    J Emerg Med. [Abstract] [Full-text]
  94. Vascular prostheses with covalently bound gentamicin and amikacin reveal superior antibacterial properties than silver-impregnated ones--an in vitro study.
    Eur J Vasc Endovasc Surg, 38(6): 697-706. [Abstract] [Full-text]
  95. Enhanced detection of staphylococcal genomes in positive blood cultures using a polymeric enzyme complex.
    Anal Biochem, 396(2): 284-9. [Abstract] [Full-text]
  96. Antimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in China from 2003 to 2007 shows community-associated methicillin-resistant Staphylococcus aureus to be uncommon and heterogeneous.
    Br J Dermatol, 161(6): 1347-50. [Abstract] [Full-text]
  97. Identification and characterisation of a Streptomyces sp. isolate exhibiting activity against methicillin-resistant Staphylococcus aureus.
    Microbiol Res, 165(1): 82-6. [Abstract] [Full-text]
  98. Skin infection in children colonized with community-associated methicillin-resistant Staphylococcus aureus.
    J Infect, 59(6): 394-401. [Abstract] [Full-text]
  99. Pediatric emergencies associated with fever.
    Emerg Med Clin North Am, 28(1): 67-84, vii-viii. [Abstract] [Full-text]
  100. Regional antibiotic delivery for the treatment of experimental prosthetic graft infections.
    J Surg Res, 157(2): 223-6. [Abstract] [Full-text]
Place a permanent text-link or advertisement here.

© 2004-2012 MRSA Research Today. All Rights Reserved.



MRSA Research Today Archive:

Volume 1 (2004)
  Issue 1 (October)
  Issue 2 (November)
  Issue 3 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 6 (2009)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 7 (2010)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 8 (2011)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 9 (2012)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)



MRSA Books

Possible risk for re-colonization with methicillin-resistant Staphylococcus aureus (MRSA) by faecal transmission [An article from: International Journal of Hygiene and Environmental Health]

Possible risk for re-colonization with methicillin-resistant Staphylococcus aureus (MRSA) by faecal transmission [An article from: International Journal of Hygiene and Environmental Health]